BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

524717

TITANBIO

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

TITAN BIOTECH LTD. Share Price Update

As of the latest trading session, TITAN BIOTECH LTD. share price is currently at ₹ 464.4, which is down by ₹ -5.10 from its previous closing. Today, the stock has fluctuated between ₹ 451.10 and ₹ 489.80. Over the past year, TITAN BIOTECH LTD. has achieved a return of -9.65 %. In the last month alone, the return has been 3.31 %. Read More...

TITAN BIOTECH LTD. fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    383.76

  • P/E Ratio (TTM)

    19.68

  • Beta

    0.74

  • Book Value / share

    166.48

  • Return on equity

    20.18%

  • EPS (TTM)

    23.41

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    3.80

info icon alternate text

TITAN BIOTECH LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 38.28
Operating Expense 34.76
Net Profit 3.80
Net Profit Margin (%) 9.92
Earnings Per Share (EPS) 4.60
EBITDA 6.43
Effective Tax Rate (%) 25.49
Particulars SEP 2024 (Values in Cr)
Revenue 39.89
Operating Expense 33.50
Net Profit 5.00
Net Profit Margin (%) 12.53
Earnings Per Share (EPS) 6.05
EBITDA 8.09
Effective Tax Rate (%) 25.44
Particulars JUN 2024 (Values in Cr)
Revenue 43.11
Operating Expense 36.22
Net Profit 5.70
Net Profit Margin (%) 13.22
Earnings Per Share (EPS) 6.90
EBITDA 8.87
Effective Tax Rate (%) 24.20
Particulars MAR 2024 (Values in Cr)
Revenue 39.92
Operating Expense 34.02
Net Profit 4.84
Net Profit Margin (%) 12.12
Earnings Per Share (EPS) 5.86
EBITDA 7.55
Effective Tax Rate (%) 24.01
Particulars DEC 2023 (Values in Cr)
Revenue 45.98
Operating Expense 36.47
Net Profit 7.38
Net Profit Margin (%) 16.05
Earnings Per Share (EPS) 8.93
EBITDA 11.03
Effective Tax Rate (%) 25.75
Particulars MAR 2024 (Values in Cr)
Revenue 164.07
Operating Expense 134.29
Net Profit 23.66
Net Profit Margin (%) 14.42
Earnings Per Share (EPS) 28.64
EBITDA 36.03
Effective Tax Rate (%) 24.96
Particulars MAR 2023 (Values in Cr)
Revenue 144.00
Operating Expense 117.83
Net Profit 21.02
Net Profit Margin (%) 14.59
Earnings Per Share (EPS) 25.44
EBITDA 31.47
Effective Tax Rate (%) 25.21
Particulars MAR 2022 (Values in Cr)
Revenue 123.55
Operating Expense 95.52
Net Profit 21.68
Net Profit Margin (%) 17.54
Earnings Per Share (EPS) 26.24
EBITDA 32.21
Effective Tax Rate (%) 25.12
Particulars MAR 2021 (Values in Cr)
Revenue 122.46
Operating Expense 84.04
Net Profit 28.77
Net Profit Margin (%) 23.49
Earnings Per Share (EPS) 34.82
EBITDA 42.14
Effective Tax Rate (%) 25.77
Particulars MAR 2020 (Values in Cr)
Revenue 69.48
Operating Expense 62.26
Net Profit 6.20
Net Profit Margin (%) 8.92
Earnings Per Share (EPS) 7.50
EBITDA 11.89
Effective Tax Rate (%) 24.75
Particulars MAR 2024 (Values in Cr)
Book Value / Share 155.43
ROE % 20.18
ROCE % 25.70
Total Debt to Total Equity 0.07
EBITDA Margin 21.96
Particulars MAR 2023 (Values in Cr)
Book Value / Share 128.38
ROE % 21.86
ROCE % 27.12
Total Debt to Total Equity 0.09
EBITDA Margin 21.85
Particulars MAR 2022 (Values in Cr)
Book Value / Share 104.36
ROE % 28.52
ROCE % 34.30
Total Debt to Total Equity 0.13
EBITDA Margin 26.07
Particulars MAR 2021 (Values in Cr)
Book Value / Share 79.65
ROE % 55.52
ROCE % 59.73
Total Debt to Total Equity 0.27
EBITDA Margin 34.46
Particulars MAR 2020 (Values in Cr)
Book Value / Share 45.76
ROE % 17.85
ROCE % 18.26
Total Debt to Total Equity 0.57
EBITDA Margin 17.13
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.84
Total Assets 156.57
Total Liabilities 156.57
Total Equity 133.45
Share Outstanding 8263700
Price to Book Ratio 3.40
Return on Assets (%) 15.87
Return on Capital (%) 17.67
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 4.86
Total Assets 134.51
Total Liabilities 134.51
Total Equity 109.91
Share Outstanding 8263700
Price to Book Ratio 1.53
Return on Assets (%) 18.46
Return on Capital (%) 21.25
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 6.81
Total Assets 108.09
Total Liabilities 108.09
Total Equity 86.24
Share Outstanding 8263700
Price to Book Ratio 2.51
Return on Assets (%) 20.06
Return on Capital (%) 23.12
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 5.45
Total Assets 100.71
Total Liabilities 100.71
Total Equity 72.47
Share Outstanding 8263700
Price to Book Ratio 2.33
Return on Assets (%) 30.11
Return on Capital (%) 35.43
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.85
Total Assets 76.03
Total Liabilities 76.03
Total Equity 41.54
Share Outstanding 8263700
Price to Book Ratio 0.93
Return on Assets (%) 9.29
Return on Capital (%) 10.97
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.84
Total Assets 151.57
Total Liabilities 151.57
Total Equity 128.44
Share Outstanding 8263700
Price to Book Ratio 3.40
Return on Assets (%) 15.61
Return on Capital (%) 17.45
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 4.86
Total Assets 130.69
Total Liabilities 130.69
Total Equity 106.09
Share Outstanding 8263700
Price to Book Ratio 1.53
Return on Assets (%) 16.08
Return on Capital (%) 18.59
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 6.81
Total Assets 108.09
Total Liabilities 108.09
Total Equity 86.24
Share Outstanding 8263700
Price to Book Ratio 2.51
Return on Assets (%) 20.06
Return on Capital (%) 23.12
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 5.30
Total Assets 86.17
Total Liabilities 86.17
Total Equity 65.82
Share Outstanding 8263700
Price to Book Ratio 2.33
Return on Assets (%) 33.39
Return on Capital (%) 39.22
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.72
Total Assets 65.19
Total Liabilities 65.19
Total Equity 37.81
Share Outstanding 8263700
Price to Book Ratio 0.93
Return on Assets (%) 9.51
Return on Capital (%) 11.34
Particulars MAR 2024 (Values in Cr)
Net Income 31.52
Cash from Operations 29.01
Cash from Investing -20.30
Cash from Financing -2.86
Net change in Cash -2.02
Free Cash Flow 48.50
Particulars MAR 2023 (Values in Cr)
Net Income 28.11
Cash from Operations 28.67
Cash from Investing -20.72
Cash from Financing -2.40
Net change in Cash -1.95
Free Cash Flow 31.75
Particulars MAR 2022 (Values in Cr)
Net Income 28.96
Cash from Operations 29.15
Cash from Investing -16.43
Cash from Financing -4.09
Net change in Cash 1.50
Free Cash Flow 35.46
Particulars MAR 2021 (Values in Cr)
Net Income 42.70
Cash from Operations 29.96
Cash from Investing -4.86
Cash from Financing -10.59
Net change in Cash 3.61
Free Cash Flow 32.97
Particulars MAR 2020 (Values in Cr)
Net Income 10.40
Cash from Operations 8.30
Cash from Investing -2.21
Cash from Financing -3.94
Net change in Cash -0.04
Free Cash Flow 8.30
Particulars MAR 2024 (Values in Cr)
Net Income 31.52
Cash from Operations 29.01
Cash from Investing -20.30
Cash from Financing -2.86
Net change in Cash -2.02
Free Cash Flow 48.50
Particulars MAR 2023 (Values in Cr)
Net Income 28.11
Cash from Operations 28.67
Cash from Investing -20.72
Cash from Financing -2.40
Net change in Cash -1.95
Free Cash Flow 31.75
Particulars MAR 2022 (Values in Cr)
Net Income 28.96
Cash from Operations 29.15
Cash from Investing -16.43
Cash from Financing -4.09
Net change in Cash 1.50
Free Cash Flow 35.46
Particulars MAR 2021 (Values in Cr)
Net Income 38.76
Cash from Operations 27.74
Cash from Investing -4.17
Cash from Financing -9.80
Net change in Cash 3.60
Free Cash Flow 30.45
Particulars MAR 2020 (Values in Cr)
Net Income 8.24
Cash from Operations 8.46
Cash from Investing -0.94
Cash from Financing -5.86
Net change in Cash 0.11
Free Cash Flow 9.03
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 37.10 19.95 2.02 284.31 34.11 / 77.70
BLISS GVS PHARMA LTD 122.65 16.07 1.27 1292.37 92.25 / 184.95
CIPLA LTD 1541.00 24.94 4.38 124457.39 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 272.25 22.56 2.76 801.26 145.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 37.10 22.35 6.30 284.31 34.11 / 77.70
AMRUTAJAN HEALTH LTD 679.10 39.81 6.59 1963.32 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8795.90 131.18 32.36 21989.75 5000.00 / 9199.00
BLISS GVS PHARMA LTD 122.65 15.93 1.26 1292.37 92.25 / 184.95

TITAN BIOTECH LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
460.80 -1.85 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 471.90
  • 26 Days 480.60
  • 10 Days 477.60
  • 50 Days 508.80
  • 12 Days 478.10
  • 100 Days 569.60
  • 20 Days 478.40
  • 200 Days 598.80
473.22 PIVOT

First Support

462.53

First Resistance

480.18

Second Support

455.57

Second Resistance

490.87

Third Support

444.88

Third Resistance

497.83

RSI

45.16

ADX

7.98

MACD

-0.94

Williams % R

-42.54

Commodity Channel Index (CCI)

-12.42

Date

2025-04-29

Week

2998.00

Same Day

723.00

Month

3848.00

1 Year

0.74

3 Year

0.66

Over 1 Month

3.31%

down

Over 1 Year

-9.65%

down

Over 3 Months

-37.13%

down

Over 3 Years

22.62%

down

Over 6 Months

-46.64%

down

Over 5 Years

55.85%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

TITAN BIOTECH LTD. shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
44.1%
Promoter Holdings
55.87%
FII
0.0%
DII
0.01%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Titan Securities Ltd 2776155.0 (33.59%) Shareholding of Promoter and Promoter Group
Tanita Leasing & Finance Limited 784455.0 (9.49%) Shareholding of Promoter and Promoter Group
Connoisseur Management Services Private Limited 560000.0 (6.78%) Shareholding of Promoter and Promoter Group
Ankit Goyal 129700.0 (1.57%) Public Shareholding
Suresh Chand Singla 105671.0 (1.28%) Shareholding of Promoter and Promoter Group
Manju Singla 71210.0 (0.86%) Shareholding of Promoter and Promoter Group
Madhu Gupta 66510.0 (0.8%) Shareholding of Promoter and Promoter Group
Raja Singla 61100.0 (0.74%) Shareholding of Promoter and Promoter Group
Supriya Singla 54493.0 (0.66%) Shareholding of Promoter and Promoter Group
Udit Singla 50000.0 (0.61%) Shareholding of Promoter and Promoter Group
Shivom Singla 35400.0 (0.43%) Shareholding of Promoter and Promoter Group
Naresh Kumar Singla 34510.0 (0.42%) Shareholding of Promoter and Promoter Group
Naresh Kumar Singla Huf 10000.0 (0.12%) Shareholding of Promoter and Promoter Group
Ravinder Gupta 7900.0 (0.1%) Shareholding of Promoter and Promoter Group
Ravinder Gupta Huf 111.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

TITAN BIOTECH LTD. corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
22 Sep 2023 1.8 Final 22 Sep 2023 Equity shares
22 Sep 2022 1.5 Final 23 Sep 2022 Equity shares
16 Sep 2021 1.5 Final 08 Sep 2021 Equity shares
17 Sep 2020 1.0 Final 19 Sep 2020 Equity shares
19 Sep 2018 0.75 Final 22 Sep 2018 Equity shares
21 Sep 2017 0.75 Final 23 Sep 2017 Equity shares
22 Sep 2016 0.75 Final 26 Sep 2016 Equity shares
22 Sep 2015 0.75 Final 24 Sep 2015 Equity shares
18 Sep 2014 0.75 Final 22 Sep 2014 Equity shares
19 Sep 2013 0.75 Final 23 Sep 2013 Equity shares
22 Sep 2011 0.75 Final 26 Sep 2011 Equity shares
23 Sep 2010 0.5 Final 25 Sep 2010 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

TITAN BIOTECH LTD. Share Price

Titan Biotech Ltd., the New Delhi based company is into manufacture of Biological Peptones, Extracts and Dehydrated Culture media which are very conducive for the growth of micro organisms. They are primarily used in the development and growth of micro organisms in clinical diagnosis production of vaccines antibiotics antisera etc, Checking the sensitivity of antibiotics in pharmaceutical industry, checking the bacterial contamination in food & water, tissue culture laboratories and in the departments of microbiology & botony in medical colleges/universities.

The company uses Meat, Bile, Pancreatic, Liver, Blood, Brain, Heart and other parts of animals souced from slaughter house and other vegetable products like soya, casein etc. converting them into free flowing powder to produce Peptones, Extracts and Hydrolysates which are further used in manufacturing of Dehydrated Culture Media and as raw material in pharma health products and other industries.

During 2006-07, Company introduced new culture media with gama radiation including readymade sterile media and dehydrated sterile media. Besides, it also introduced lab chemicals and agaroses to serve microbiology research institutes and in various applications of microbiology like food, aquatic, veretinary, cosmetics, pharma, heaith care, medical environment. It developed Amino acid Chelates and harmonized media in 2009-10.

Parent organization Indian Private
NSE symbol [-]
Founded 1992
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Titan Biotech Ltd?

Answer Field

The share price of Titan Biotech Ltd for NSE is ₹ 0.00 and for BSE is ₹ 460.80.

What is the Market Cap of Titan Biotech Ltd?

Answer Field

The market cap of Titan Biotech Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 3,80.80 Cr. as of now.

What is the 52 Week High and Low of Titan Biotech Ltd?

Answer Field

The 52 Week High and Low of Titan Biotech Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 1017.85 and ₹ 406.70.

How to Buy Titan Biotech Ltd share?

Answer Field

You can trade in Titan Biotech Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Titan Biotech Ltd?

Answer Field

The 1 year returns on the stock has been -11.52%.

What is the Current Share Price of Titan Biotech Ltd?

Answer Field

Titan Biotech Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 460.80 as on Apr 30 2025 03:28 PM.

What is the Market Cap of Titan Biotech Ltd Share?

Answer Field

The market cap of Titan Biotech Ltd for NSE ₹ 0.0 & for BSE ₹ 3,80.80 as on Apr 30 2025 03:28 PM.

What is the P/E Ratio of Titan Biotech Ltd Share?

Answer Field

As on Apr 30 2025 03:28 PM the price-to-earnings (PE) ratio for Titan Biotech Ltd share is 19.68.

What is the PB ratio of Titan Biotech Ltd Share?

Answer Field

As on Apr 30 2025 03:28 PM, the price-to-book (PB) ratio for Titan Biotech Ltd share is 166.48.

How to Buy Titan Biotech Ltd Share?

Answer Field

You can trade in Titan Biotech Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Titan Biotech Ltd Share on Bajaj Broking App?

Answer Field

To buy Titan Biotech Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Titan Biotech Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|